Pharmacy Guide
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Pharmacy Guide
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets GSL
⚠ This medicine appears to have been discontinued
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Loratadine may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
What it is and what it is used for
for The full name of your medicine is Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets. What Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets are Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets contain the active substance loratadine which belongs to a class of medicines called "antihistamines". How Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets work Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets help to reduce your allergy symptoms by stopping the effects of a substance called "histamine", which is produced in the body when you are allergic to something. When Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets should be taken Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets relieve symptoms associated with allergic rhinitis (for example, hay fever) such as sneezing, runny or itchy nose, and burning or itchy eyes. Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets may also be used to relieve symptoms of urticaria (itching and redness) which is often known as hives or nettle rash. The effect of Well Pharmaceuticals One-aDay Allergy Relief 10mg tablets will last a whole day and should help you to continue your normal daily activities and sleep. You must talk to a doctor if you do not feel better or if you feel worse.
What you need to know before you take it
e Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets Do not take Well Pharmaceuticals One-aDay Allergy Relief 10mg tablets if:
- you are allergic (hypersensitive) to loratadine or any of the other ingredients of this medicine (listed in section 6).
- you are pregnant or breast-feeding
Warnings and precautions Talk to your doctor, pharmacist or nurse before taking Well Pharmaceuticals One-aDay Allergy Relief 10mg tablets if:
- you have liver disease
- you are scheduled to have any skin tests for allergies. Do not take Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets for two days before having these tests. This is because it may affect the test results. If any of the above apply to you (or you are not sure), talk to your doctor, pharmacist or nurse before taking Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets. Children Do not give Well Pharmaceuticals One-aDay Allergy Relief 10mg tablets to children younger than 6 years old or to children who weigh 30 kg or less. There are other formulations more suitable for children younger than 6 years or with a body weight of 30 kg or less. Children under 2 years of age: The safety and efficacy of Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets have not been established. No data are available. Other medicines and Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets The side effects of Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets may increase when used together with medicines that alter the performance of some enzymes responsible for drugmetabolism in the liver. However, in the clinical studies, no increase in side effects of loratadine was seen with products that altered the performance of these enzymes. Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines. This includes medicines taken without a prescription. Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets with alcohol Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets have not been shown to add to the effects of an alcoholic drink. Pregnancy and breast-feeding If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. As a precautionary measure, it is preferable to avoid the use of Well Pharmaceuticals Onea-Day Allergy Relief 10mg tablets during pregnancy. Do not take Well Pharmaceuticals One-aDay Allergy Relief 10mg tablets if you are breast-feeding. Loratadine is excreted in breast milk. Driving and using machines In clinical trials that assessed driving ability, no impairment was observed in patients receiving loratadine. At the recommended dose, Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets are not expected to cause you to be drowsy or less alert. However, very rarely some people experience drowsiness, which may affect their ability to drive or use machines. Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets contain lactose This medicinal product contains lactose; thus, if you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
How to take it
Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets Always take this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse has told you. Check with your doctor, pharmacist or nurse if you are not sure. Press the tablet through foil from the other side.
Giving this medicine to children It is important to know how much your child weighs to make sure that you give the correct amount of medicine. For example, a 9 year old child weighs about 30kg (4st 7lb). If in doubt weigh your child and then follow the instructions in the table. Do not give to children who weigh 30 kg (4st 7lb) or less. There are other formulations more suitable for children younger than 6 years or with a body weight of 30 kg or less. Not recommended for children less under 2 years old.
Reporting of side effects If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Possible side effects
, although not everybody gets them.
Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the blister after Exp. The expiry date refers to the last day of the month. Do not use this medicine if you notice any change in the appearance of the tablet. Store in the original package. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
How to store it
Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets
How much to take: How much to take
How often to take
Adults and children 6 years and older who weigh more than 30 kg (4st 7lb)
1 x tablet
Once daily
Children who weigh 30kg (4st 7lb) or less
Not recommended.
Age and weight
If you have severe liver problems your doctor or pharmacist may advise you to take the recommended amount every other day. If this applies to you follow their instructions.
If you take more Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets than you should If you take more Well Pharmaceuticals Onea-Day Allergy Relief 10mg tablets than you should, talk to your doctor or pharmacist straight away. No serious problems are expected however, you may get a headache, have a rapid heartbeat or feel sleepy. If you forget to take Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets
- If you forget to take your dose, take it as soon as you remember, then continue to take it as usual.
- Do not take a double dose to make up for a forgotten dose. If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse. 4) Possible side effects Like all medicines, this medicine can cause
Contents of the pack and other information
What Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets contain
- The active substance is loratadine. Each tablet contains 10 mg loratadine.
- The other ingredients are lactose monohydrate, maize starch, magnesium stearate. What Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets look like and contents of the pack Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets are white to off-white, round tablets debossed with 'R' on one side and '10' on the other. Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets are available in pack sizes of 7, 14 or 30 tablets. Not all pack sizes may be marketed Marketing Authorisation Holder and Manufacturer
The most commonly reported side effects in adults and children over 12 years of age are:
- drowsiness
- headache
- increased appetite
- difficulty sleeping
Marketing Authorisation Holder: SUN PHARMA UK LIMITED 6-9 The Square, Stockley Park, Uxbridge, UB11 1FW United Kingdom
The most commonly reported side effects in children aged 2 to 12 years are:
- headache
- nervousness
- tiredness
Manufacturer: Sun Pharmaceutical Industries Europe B.V. Polarisavenue 87 2132 JH Hoofddorp The Netherlands
The following very rare side effects (may affect up to 1 in 10,000 people) have also been seen during the marketing of loratadine:
- severe allergic reaction (including swelling)
- dizziness
- convulsion
- fast or irregular heartbeat
- nausea (feeling sick)
- dry mouth
- upset stomach
- liver problems
- hair loss
- rash
- tiredness
Alkaloida Chemical Company Zrt. Kabay János u. 29 4440 Tiszavasvári Hungary
The frequency of the following side effect is not known:
- weight gain
This leaflet was last revised in September 2025.
5265534
Well Pharmaceuticals One-a-Day Allergy Relief 10 mg
Frequently asked questions about Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets GSL
How do I take Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets GSL?
Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets GSL comes as tablet containing 10mg. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
What is the active substance in Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets GSL?
The active substance in Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets GSL is loratadine.
Are there equivalent medicines to Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets GSL?
Medicines with the same active substance, strength and form include: Boots One-a-Day Allergy Relief 10mg Tablets (P & GSL), Brown & Burk Once-A-Day Hayfever & Allergy 10mg Tablets, Clarityn Allergy 10mg Tablets (GSL). In total there are 6 equivalent products. They are interchangeable only if your prescriber or pharmacist says so.
Where does this information come from?
This leaflet reproduces the patient information leaflet approved for Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets GSL, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Can I get Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets GSL without a prescription?
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
About this leaflet
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
- Source: electronic medicines compendium (emc), Datapharm
- Active substance: loratadine
- Official document: view the original leaflet on emc →
⚕For healthcare professionals — Summary of Product Characteristics (SmPC)Full SmPC: dosage, interactions, contraindications, warnings+
4.1. Therapeutic indications
Roletra 10 mg tablets are indicated for the symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children over the age of 2 years with a body weight more than 30kg.
4.2. Posology and method of administration
Posology
Adults and children over 12 years of age:
10mg once daily (one tablet once daily)
Paediatric population
Children 2 to 12 years of age are dosed by weight:
Body weight more than 30kg: 10mg once daily (one tablet once daily).
Body weight 30kg or less: The 10mg strength tablet is not appropriate in children with a body weight less than 30kg. There are other formulations more suitable for children 2 to 12 years old with body weight 30 kg or less.
Safety and efficacy of Roletra 10 mg tablets in children under 2 years of age has not been established. No data are available.
Patients with hepatic treatment
Patients with severe liver impairment should be administered a lower initial dose because they may have reduced clearance of loratadine. An initial dose of 10mg every other day is recommended for adults and children weighing more than 30kg.
Patients with renal impairment
No dosage adjustments are required in patients with renal insufficiency.
Older people
No dosage adjustments are required in older people.
Method of administration
Oral use. The tablet may be taken without regard to mealtime.
4.3. Contraindications
Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
4.4. Special warnings and precautions for use
Roletra 10 mg Tablets should be administered with caution in patients with severe liver impairment (see section 4.2).
The administration of Roletra 10 mg tablets should be discontinued at least 48 hours before skin tests since antihistamines may prevent or reduce otherwise positive reactions to dermal reactivity index.
This medicinal product contains lactose monohydrate. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.
4.5. Interaction with other medicinal products and other forms of interaction
When administered concurrently with alcohol, loratadine has no potentiating effects as measured by psychomotor performance studies.
Loratadine is metabolised by hepatic cytochromes P450 3A4 and 2D6.
Potential interaction may occur with all known inhibitors of CYP3A4 or CYP2D6 resulting in elevated levels of loratadine (see Section 5.2), which may cause an increase in adverse events.
Increase in plasma concentrations of loratadine has been reported after concomitant use with ketoconazole, erythromycin, and cimetidine in controlled trials, but without clinically significant changes (including electrocardiographic).
Paediatric population
Interaction studies have only been performed in adults.
4.6. Fertility, pregnancy and lactation
Pregnancy
A large amount of data on pregnant women (more than 1000 exposed outcomes) indicate no malformative nor feto/ neonatal toxicity of loratadine. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity (see section 5.3).
As a precautionary measure, it is preferable to avoid the use of Roletra 10mg Tablets during pregnancy.
Breast-feeding
Physico-chemical data suggest excretion of loratadine/metabolites in human milk. A risk to the newborns/infants cannot be excluded. Roletra 10mg Tablets should not be used during breast-feeding.
Fertility
There are no data available on male and female fertility.
4.7. Effects on ability to drive and use machines
Roletra 10mg tablets has no or negligible influence on the ability to drive and use machines. However, patients should be informed that very rarely some people experience drowsiness, which may affect their ability to drive or use machines.
4.8. Undesirable effects
Summary of the safety profile
In clinical trials involving adults and adolescents in a range of indications including allergic rhinitis (AR) and chronic idiopathic urticarial (CIU), at the recommended dose of 10mg daily, adverse reactions with loratadine were reported in 2% of patients in excess of those treated with placebo. The most frequent adverse reactions reported in excess of placebo were somnolence (1.2%), headache (0.6%), increased appetite (0.5%) and insomnia (0.1%).
Tabulated list of adverse reactions
The following adverse reactions reported during the post-marketing period are listed in the following table by System Organ Class. Frequencies are defined as very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to < 1/1,000), very rare (< 1/10,000) and not known (cannot be estimated from the available data).
Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
System Organ Class
Frequency
Adverse Experience Term
Immune system disorders
Very rare
Hypersensitivity reactions (including angioedema and anaphylaxis)
Nervous system disorders
Very rare
Dizziness, convulsion
Cardiac disorders
Very rare
Tachycardia, palpitation
Gastrointestinal disorders
Very rare
Nausea, dry mouth, gastritis
Hepatobiliary disorders
Very rare
Abnormal hepatic function
Skin and subcutaneous tissue disorders
Very rare
Rash, alopecia
General disorders and administration site conditions
Very rare
Fatigue
Investigations
Not known
Weight increased
Paediatric population
In clinical trials in a paediatric population, children aged 2 through 12 years, common adverse reactions reported in excess of placebo were headache (2.7%), nervousness (2.3%), and fatigue (1%).
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme, website www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
4.9. Overdose
Overdosage with loratadine increased the occurrence of anticholinergic symptoms. Somnolence, tachycardia, and headache have been reported with overdoses.
In the event of overdosage, general symptomatic and supportive measures are to be instituted and maintained for as long as necessary. Administration of activated charcoal as a slurry with water may be attempted. Gastric lavage may be considered. Loratadine is not removed by haemodialysis and it is not known if loratadine is removed by peritoneal dialysis. Medical monitoring of the patient is to be continued after emergency treatment.
💬 Ask about this leaflet
Ask anything about Well Pharmaceuticals One-a-Day Allergy Relief 10mg tablets GSL. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.